A randomized comparison of doxorubicin alone versus doxorubicin plus cyclophosphamide in the management of advanced or recurrent endometrial carcinoma: A Gynecologic Oncology Group Study

J. T. Thigpen, J. A. Blessing, P. J. DiSaia, E. Yordan, L. F. Carson, C. Evers

Research output: Contribution to journalArticlepeer-review

162 Scopus citations

Fingerprint

Dive into the research topics of 'A randomized comparison of doxorubicin alone versus doxorubicin plus cyclophosphamide in the management of advanced or recurrent endometrial carcinoma: A Gynecologic Oncology Group Study'. Together they form a unique fingerprint.

Medicine & Life Sciences